Table 3: Determinants of serum NfL levels within the study population.
Unadjusted | Adjusted | |||
---|---|---|---|---|
β(SE) | p-Value | β(SE) | p-Value | |
Age in years | 0.48 (0.09) | <0.01 | 0.36 (0.09) | <0.01 |
Female | −0.95 (1.24) | 0.44 | ||
Non-Caucasian race | 4.71 (1.38) | <0.01 | 3.57 (1.33) | <0.01 |
Cardiovascular disease history | 1.66 (1.29) | 0.20 | ||
Cigarette smoking history | 0.31 (1.85) | 0.87 | ||
Left ventricular hypertrophy | 0.73 (1.16) | 0.53 | ||
Antihypertensive medication use | −0.003 (1.61) | 0.99 | ||
Systolic blood pressure | 0.16 (0.03) | <0.01 | 0.11 (0.03) | <0.01 |
Diastolic blood pressure | −0.01 (0.06) | 0.81 | ||
Glomerular filtration rate <60 ml/min/1.73m2 | 9.87 (1.97) | <0.01 | 8.01 (1.92) | <0.01 |
Total cholesterol | 0.03 (0.01) | 0.07 | ||
High density lipoprotein | 0.12 (0.05) | 0.01 | 0.03 (0.05) | 0.36 |
Low density lipoprotein | 0.04 (0.02) | 0.04 | 0.02 (0.02) | 0.13 |
Triglycerides | −0.004(0.004) | 0.37 | ||
Years of diabetes | 0.25 (0.08) | <0.01 | 0.09 (0.08) | 0.27 |
Hemoglobin A1C | 1.95 (0.67) | <0.01 | 1.85 (0.64) | <0.01 |